Myocardin is sufficient for a smooth muscle-like contractile phenotype

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1505-10. doi: 10.1161/ATVBAHA.108.166066. Epub 2008 May 1.

Abstract

Background: Myocardin (Myocd) is a strong coactivator that binds the serum response factor (SRF) transcription factor over CArG elements embedded within smooth muscle cell (SMC) and cardiac muscle cyto-contractile genes. Here, we sought to ascertain whether Myocd-mediated gene expression confers a structural and physiological cardiac or SMC phenotype.

Methods and results: Adenoviral-mediated expression of Myocd in the BC(3)H1 cell line induces cardiac and SMC genes while suppressing both skeletal muscle markers and cell growth. Immunofluorescence microscopy shows that SRF and a SMC-like cyto-contractile apparatus are elevated with Myocd overexpression. A short hairpin RNA to Srf impairs BC(3)H1 cyto-architecture; however, cotransduction with Myocd results in complete restoration of the cyto-architecture. Electron microscopic studies demonstrate a SMC ultrastructural phenotype with no evidence for cardiac sarcomerogenesis. Biochemical and time-lapsed videomicroscopy assays reveal clear evidence for Myocd-induced SMC-like contraction.

Conclusions: Myocd is sufficient for the establishment of a SMC-like contractile phenotype.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / physiology*
  • Cell Line, Tumor
  • Humans
  • Mice
  • Muscle Contraction / physiology
  • Muscle, Skeletal / physiology*
  • Myocytes, Smooth Muscle / physiology*
  • Neovascularization, Pathologic / physiopathology
  • Nuclear Proteins / physiology*
  • Trans-Activators / physiology*

Substances

  • Nuclear Proteins
  • Trans-Activators
  • myocardin